News: EGF receptor inhibitors

Cohen’s Nobel-Winning Work Stands Test of Time

Thursday, December 8th, 2011

Twenty-five years ago on Dec. 10, King Carl XVI Gustaf of Sweden presented the Nobel Prize to Vanderbilt biochemist Stanley Cohen, Ph.D., for his discovery and characterization of epidermal growth factor (EGF) and its receptor. At the time, the implications of Cohen’s discovery two decades earlier had barely begun to be realized. Today the EGF […]

Arteaga Earns Komen Award

Friday, October 7th, 2011

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the winners of this year’s Susan G. Komen for the Cure Brinker Awards for Scientific Distinction. The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of […]